QR Pharma’s Posiphen® was shown in a Clinical Mechanism of Action Study to Enter the Brain and to Inhibit Amyloid Precursor Protein

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply